PCV6 LONG-TERM COST-EFFECTIVENESS OF EARLY AND SUSTAINED DUAL ORAL ANTIPLATELET THERAPY WITH CLOPIDOGREL FOLLOWING PERCUTANEOUS CORONARY INTERVENTION (CREDO TRIAL)- A FOUR-EUROPEAN COUNTRY ANALYSIS
Abstract
Authors
WS Weintraub O Bouin E Veledar S Gabriel